4//SEC Filing
Intellia Therapeutics, Inc. 4
Accession 0001209191-17-037516
$NTLACIK 0001652130operating
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 7:59 AM ET
Size
4.8 KB
Accession
0001209191-17-037516
Insider Transaction Report
Form 4
Bell Graeme
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
2017-06-02$12.37/sh+8,400$103,938→ 8,400 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.25 to $12.49, inclusive.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001652130
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 7:59 AM ET
- Size
- 4.8 KB